3 New Strong Buy Ratings from Top-Rated Analysts: 06/12/2026

Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

• Dycom Industries Inc (DY) — Fiber buildout champion targets 45% upside on telecom boom.
• Omnicell, Inc. (OMCL) — Healthcare automation play eyes 349% earnings surge ahead.
• Orion Group Holdings Inc (ORN) — Marine construction stock targets 222% earnings explosion ahead.

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

1. Dycom Industries (NYSE: DY)

Fiber optic and 5G infrastructure are exploding — and this telecom buildout specialist is right at the center of it all. Providing specialized program management, engineering, construction, maintenance, and installation services for telecommunications providers and utilities across the United States, Dycom sits at the intersection of multiple secular growth trends with surging earnings estimates and strong momentum.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $445.89 — get current quote

Max 1-year forecast: $654.00

Why we're watching:

• Analyst support: Analysts are picking up what DY is putting down. It has ONLY Strong Buy recommendations — 8 of them in fact — with forecasts suggesting over 40% upside potential in the coming year. See the recommendations. 
• For instance, KeyBanc researcher Sangita Jain (a top 7% rated analyst) maintains a Strong Buy rating with a price target that suggests nearly 40% upside, noting that Dycom's recent performance solidifies its industry position and that continued investments in workforce development and infrastructure will underpin future growth.
• Industry ranking context: Dycom is currently the 3rd highest-rated stock in the Engineering & Construction industry, which boasts a strong A Industry Rating across 41 companies.
• Zen Rating highlights: As an A-rated stock, DY is recommended as a Strong Buy by our quant ratings system — an elite tier of stocks that has historically trounced the S&P.
• Component Grades: Dycom earns an A in both Growth and Sentiment, and an above-average B for Momentum. (See all 7 Zen Component Grades here)

2. Orion Group Holdings (NYSE: ORN)

Fresh 52-week highs and swelling cash flows signal that this specialized construction firm is firing on all cylinders. Serving the infrastructure, industrial, and building sectors with specialized services both on and off the water across the U.S., Canada, and the Caribbean basin, Orion is capitalizing on increased infrastructure spending and surging marine construction demand.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $13.32 — get current quote

Max 1-year forecast: $19.00

Why we're watching:

• The stock has surged +115.68% from its 52-week low of $6.44, demonstrating powerful momentum as investors recognize the company's improving fundamentals and infrastructure spending tailwinds. Yet our Zen Ratings and top-rated analysts believe there could be room for more. 
• Analyst support: Orion enjoys unanimous Strong Buy ratings from all 4 covering analysts, demonstrating exceptional Wall Street confidence. See all recommendations
• For example, B. Riley Securities' Alex Rygiel (a top 2% rated analyst) maintains a Strong Buy rating with a $17 price target (+27.63% upside), reflecting conviction in Orion's market positioning and project pipeline.
• Industry ranking context: Orion is currently the 2nd highest-rated stock in the Engineering & Construction industry, which boasts a strong A Industry Rating, positioning the company among the elite in a highly-rated sector.
• Zen Rating highlights: Strong Buy (A) stocks average nearly 30% annually. This puts ORN in a class of historical outperformers that have beaten the S&P for decades. 
• Component Grades: Orion earns an A in Growth with strong performance in Momentum (B) and Sentiment (B), alongside a B in Safety, though Value and Financials remain at C reflecting the company's smaller scale and growth investment phase. (See all 7 Zen Component Grades here)

3. Omnicell (NASDAQ: OMCL)

A quiet healthcare automation play is positioning itself as the market's next big surprise. Delivering advanced medication management solutions that help hospitals and pharmacies automate and optimize medication dispensing, tracking, and analytics, Omnicell is gaining traction with recent leadership appointments including Dan Mandoli to lead the Specialty Pharmacy Services business and participation in the Goldman Sachs Global Healthcare Conference.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $38.18 — get current quote

Max 1-year forecast: $70.00

Why we're watching:

• Analyst support: Omnicell benefits from unanimous Strong Buy ratings across all 4 covering analysts, with max forecasts suggesting over 80% upside potential in the coming year. See all recommendations
• Among the bullish coverage, Benchmark researcher Bill Sutherland (a top 12% rated analyst) maintains a Strong Buy rating with a $60 price target (+57.15% upside), expecting management to guide ahead of FY 2026 consensus numbers when reporting Q4 and FY 2025 earnings. 
• Industry ranking context: Omnicell is currently the #1 highest-rated stock in the Health Information Service industry, which carries a C Industry Rating across 45 companies.
• Zen Rating highlights: As an A-rated stock, OMCL is in our top echelon of stocks tracked — meaning it has passed our rigorous 115-factor review and come out sparkling. 
• Component Grades: Omnicell earns As in Growth and an A in Sentiment, alongside a B in Value, B in Safety, with only moderate scores in Financials (C), AI applications (C) and Momentum (C) reflecting the company's transition phase. (See all 7 Zen Component Grades here)

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.